The Oncology Institute, Inc. (TOI)
TOI moved a median of -0.03% 30 minutes after news, and -0.36% by the close. How TOI actually reacts to news — the realized, point-in-time move the market made, measured across 350 labeled events over the last three years with zero look-ahead.
TOI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 44% | 317 |
| 30-min | -0.03% | 47% | 340 |
| 60-min | -0.33% | 45% | 346 |
| to close | -0.36% | 44% | 347 |
| Middle 50% of TOI reactions | -2.26% to +1.74% |
|---|---|
| Median reaction (30-min) | -0.03% |
| Measured reactions | 350 |
Half of all The Oncology Institute, Inc. news events land between -2.26% and +1.74% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How TOI reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 16 | -0.72% | 38% | -0.18% |
| Rating reiterations | 14 | +0.38% | 79% | +1.11% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how TOI ranks against every other measured name →
That’s how TOI usually reacts — get an email when it moves on news →Email me when TOI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TOI's baseline. Nothing else.
Recent TOI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Oncology Institute, Inc. For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | +0.51% | +4.06% | |
| The Oncology Institute Rebrands as Starling Oncology | Press release | GlobeNewswire | +0.51% | +4.06% | |
| The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call | Press release | GlobeNewswire | +4.37% | +3.18% | |
| Form 8-K Oncology Institute, Inc. For: Jul 01 | SEC filing · Form 8-K | SEC EDGAR | -1.05% | -1.05% | |
| The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity | Press release | GlobeNewswire | +0.73% | +6.42% | |
| Form 8-K Oncology Institute, Inc. For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | -0.76% | -4.93% | |
| The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference | Press release | GlobeNewswire | +0.22% | -0.43% | |
| Form 8-K Oncology Institute, Inc. For: May 20 | SEC filing · Form 8-K | SEC EDGAR | +0.22% | -0.43% | |
| The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference | Press release | GlobeNewswire | +1.50% | +2.00% | |
| Form 10-Q Oncology Institute, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.99% | -1.24% | |
| Form 8-K Oncology Institute, Inc. For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +0.99% | -1.24% | |
| The Oncology Institute Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | +0.99% | -1.24% | |
| Form DEF 14A Oncology Institute, Inc. For: Jun 17 | SEC filing · Form DEF | SEC EDGAR | +5.70% | +4.92% | |
| Form DEFA14A Oncology Institute, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +5.70% | +4.92% | |
| Form ARS Oncology Institute, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.29% | +8.16% | |
| The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call | Press release | GlobeNewswire | +0.15% | +2.46% | |
| The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement | Press release | GlobeNewswire | +1.29% | +6.80% | |
| The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference | Press release | GlobeNewswire | +0.81% | +0.97% | |
| The Oncology Institute Names Minh Merchant Chief Legal Officer | Press release | GlobeNewswire | +3.83% | +2.56% | |
| Form 8-K Oncology Institute, Inc. For: Mar 13 | SEC filing · Form 8-K | SEC EDGAR | +6.83% | +17.59% | |
| Form 10-K Oncology Institute, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.94% | -10.69% | |
| Form 8-K Oncology Institute, Inc. For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | -0.94% | -10.69% | |
| The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 | Press release | GlobeNewswire | -0.94% | -10.69% | |
| The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call | Press release | GlobeNewswire | -2.10% | +4.56% | |
| The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March | Press release | GlobeNewswire | +0.00% | +9.16% | |
| Form 8-K Oncology Institute, Inc. For: Feb 23 | SEC filing · Form 8-K | SEC EDGAR | -2.22% | +0.39% | |
| The Oncology Institute Appoints Kim Tzoumakas to Board of Directors | Press release | GlobeNewswire | -3.11% | -0.78% | |
| Form 8-K Oncology Institute, Inc. For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | +0.24% | -7.89% | |
| The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook | Press release | GlobeNewswire | +0.24% | -7.89% | |
| The Oncology Institute Announces Leadership Promotions | Press release | GlobeNewswire | +0.00% | -5.00% | |
| U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care | Press release | GlobeNewswire | +0.24% | -7.89% | |
| Form 8-K Oncology Institute, Inc. For: Jan 02 | SEC filing · Form 8-K | SEC EDGAR | -0.25% | +5.90% | |
| The Oncology Institute Announces Addition of Board Member Mark Stolper | Press release | GlobeNewswire | -1.09% | +6.81% | |
| Form 8-K Oncology Institute, Inc. For: Nov 26 | SEC filing · Form 8-K | SEC EDGAR | -0.34% | +0.34% | |
| The Oncology Institute Announces Resignation of Board Member Gabe Ling | Press release | GlobeNewswire | +0.00% | -3.92% | |
| Form 8-K Oncology Institute, Inc. For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +6.35% | +26.03% | |
| Form 8-K Oncology Institute, Inc. For: Nov 03 | SEC filing · Form 8-K | SEC EDGAR | -0.55% | -3.41% | |
| The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call | Press release | GlobeNewswire | +1.59% | +4.77% | |
| The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference | Press release | GlobeNewswire | -0.88% | -0.57% | |
| The Oncology Institute Partners with Protocol Behavioral Health to Integrate Mental Health Services into Cancer Care | Press release | GlobeNewswire | +0.00% | -2.54% | |
| The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation | Press release | GlobeNewswire | +1.12% | +9.27% | |
| The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos | Press release | GlobeNewswire | +3.09% | -0.31% | |
| The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida | Press release | GlobeNewswire | -1.72% | +6.60% | |
| Form 10-Q Oncology Institute, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.61% | -8.02% | |
| Form 8-K Oncology Institute, Inc. For: Aug 08 | SEC filing · Form 8-K | SEC EDGAR | +1.61% | -8.02% | |
| Form 8-K Oncology Institute, Inc. For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +1.61% | -8.02% | |
| The Oncology Institute Announces Changes to Board of Directors | Press release | GlobeNewswire | +1.61% | -8.02% | |
| The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance | Press release | GlobeNewswire | +1.61% | -8.02% | |
| The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call | Press release | GlobeNewswire | +1.10% | +1.38% | |
| The Oncology Institute Names Kristin England as Chief Administrative Officer | Press release | GlobeNewswire | -2.78% | -8.33% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TOI section they belong to.
Where else TOI is measured.
TOI earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is The Oncology Institute, Inc.'s median reaction calculated?
Every labeled TOI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 350 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 47% of TOI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TOI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.